arrow
Y

Yvan Vandenplas

Vrije Universiteit Brussel
H指数:82
被引数:3.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An Infant Formula with Partially Hydrolyzed Whey and Intact Protein Demonstrates Adequate Growth and Safety: A 6-Month Randomized, Triple-Blind, Controlled Trial

部分乳清蛋白水解和完整蛋白质的婴儿配方奶粉显示出足够的生长和安全性:一项6个月的随机、三盲、对照试验

2026-02-270
OAAI
Correction: Partially hydrolyzed; whey-based infant formula with six human milk oligosaccharides; B. infantis LMG11588; and B. lactis CNCM I-3446 is safe; well tolerated; and improves gut health: a staged analysis of a randomized trial

更正:部分水解的;基于乳清的婴儿配方奶粉,含有六种人乳寡糖;B. infantis LMG11588;以及B. lactis CNCM I-3446是安全的;耐受性良好;并能改善肠道健康:一项随机试验的阶段性分析

2025-09-200
OAAI
Partially hydrolyzed; whey-based infant formula with six human milk oligosaccharides; B. infantis LMG11588; and B. lactis CNCM I-3446 is safe; well tolerated; and improves gut health: a staged analysis of a randomized trial

部分水解; 含六种人乳低聚糖的乳清婴儿配方奶粉; B. infantis LMG11588; 和B. lactis CNCM I-3446是安全的; 耐受性良好; 并改善肠道健康: 一项随机试验的分阶段分析

2025-07-230
OA
Evaluating the Need for Pre-CoMiSS™, a Parent-Specific Cow's Milk-Related Symptom Score: A Qualitative Study

评估Pre-CoMiSS™(一种父母特异性的牛奶相关症状评分)的必要性:一项定性研究

2025-04-300
OA
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update - XI - Milk supplement/replacement formulas for infants and toddlers with CMA - Systematic review

世界过敏组织 (WAO) 对牛奶过敏的诊断和行动原理 (DRACMA) 指南更新-XI-CMA婴幼儿的牛奶补充剂/替代配方-系统评价

2024-09-010
OAAI